Variant report
Variant | esv2534255 |
---|---|
Chromosome Location | chr1:170470684-170472338 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000231407 | chromatin interactions |
ENSG00000120370 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs565724340 | chr1:170470690-170470691 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs536245094 | chr1:170470728-170470729 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs4325194 | chr1:170470769-170470770 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs192264746 | chr1:170470815-170470816 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs141474391 | chr1:170470826-170470827 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs184514939 | chr1:170470837-170470838 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs146977581 | chr1:170470894-170470895 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs190785987 | chr1:170470906-170470907 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs540977021 | chr1:170470949-170470950 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs552852843 | chr1:170470970-170470971 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs572311534 | chr1:170470998-170470999 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs543024138 | chr1:170471014-170471015 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs74815742 | chr1:170471015-170471016 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs112790771 | chr1:170471026-170471027 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs531860834 | chr1:170471042-170471043 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs544015995 | chr1:170471052-170471053 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs4402174 | chr1:170471101-170471102 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs532851699 | chr1:170471111-170471112 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs548060907 | chr1:170471114-170471115 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs566383370 | chr1:170471169-170471170 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs142184290 | chr1:170471191-170471192 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs548187979 | chr1:170471239-170471240 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs150102999 | chr1:170471270-170471271 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs537191476 | chr1:170471289-170471290 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs138451698 | chr1:170471318-170471319 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs11584810 | chr1:170471343-170471344 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs181939237 | chr1:170471356-170471357 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs552814102 | chr1:170471381-170471382 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs184484626 | chr1:170471442-170471443 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs189054790 | chr1:170471526-170471527 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs554982598 | chr1:170471612-170471613 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs548241980 | chr1:170471646-170471647 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs576448053 | chr1:170471733-170471734 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs181248437 | chr1:170471749-170471750 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs568485637 | chr1:170471788-170471789 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs565379440 | chr1:170471814-170471815 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs185605970 | chr1:170471819-170471820 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs541658779 | chr1:170471925-170471926 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
39 | rs559765736 | chr1:170471985-170471986 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
40 | rs530461732 | chr1:170471988-170471989 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
41 | rs200256944 | chr1:170472012-170472013 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
42 | rs2104918 | chr1:170472013-170472014 | Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs528756669 | chr1:170472025-170472026 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
44 | rs530430542 | chr1:170472028-170472029 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
45 | rs368945924 | chr1:170472058-170472059 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
46 | rs1970116 | chr1:170472076-170472077 | Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs532093198 | chr1:170472077-170472078 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
48 | rs534483737 | chr1:170472089-170472090 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
49 | rs546418819 | chr1:170472095-170472096 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
50 | rs535442290 | chr1:170472284-170472285 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Liposarcoma | 21253554 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 21183584 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Rett syndrome | 21593744 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Bladder cancer | 19088036 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 21858162 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chordoma | 18071362 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Trisomy 5 syndrome | 21098271 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Breast cancer | 21611746 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Cancer | 17060936 | CNVD |
Lung cancer | 16740712 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Williams-beuren syndrome | 16971481 | CNVD |
Developmental delay | 21147756 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 20164920 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:170464400-170471200 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
2 | chr1:170469000-170470800 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
3 | chr1:170470800-170471000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr1:170470800-170471000 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
5 | chr1:170470800-170471600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
6 | chr1:170471000-170471400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
7 | chr1:170471000-170472400 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
8 | chr1:170471200-170471400 | Enhancers | H1 Cell Line | embryonic stem cell |
9 | chr1:170471200-170471400 | Enhancers | H9 Cell Line | embryonic stem cell |
10 | chr1:170471200-170471400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
11 | chr1:170471200-170471400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
12 | chr1:170471400-170472400 | Weak transcription | H1 Cell Line | embryonic stem cell |
13 | chr1:170471400-170472400 | Weak transcription | H9 Cell Line | embryonic stem cell |
14 | chr1:170471400-170472400 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
15 | chr1:170471400-170472400 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
16 | chr1:170471400-170472400 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |